CSI Market
Sign In | Register

Elanco Animal Health Incorporated (ELAN) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access ELAN quarterly Cash Flow →
This cash flow overview for Elanco Animal Health Incorporated spans from Dec 31 2021 to Dec 31 2025, illustrating how cash generation and usage have shifted across recent reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income-232.00
Depreciation & amortization680.00
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Goodwill, Impairment Loss0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-57.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Business0.00
Share-based Compensation68.00
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Business Combination Inventories Step Up Fair Value Adjustment-
Inventory Fair Value Step Up Amortization-
Proceeds From Derivative Instrument Operating Activities-
Purchase And Sale Agreement Sold Portion Of Royalty Revenue71.00
Purchase And Sale Agreement Interest On Liability For Sale Of Future Revenue-
Income taxes-140.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts and Other Receivables-12.00
Increase (Decrease) in Accounts Payable and Other Operating Liabilities147.00
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets0.00
Other Working Capital21.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities14.00
Discontinued operations0.00
Net Cash flow from Operating Activities560.00
Investing Activities
Capital Expenditures-276.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Proceeds from Hedge, Investing Activities0.00
Proceeds From Previous Divestiture Of Businesses-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Proceeds from Divestiture of Businesses9.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities-12.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-279.00
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings2,106.00
Long-term debt - repayments-2,669.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-470.00
Proceeds From Payments To Transactions With Parent-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents468.00
Proceeds From Funding Related To Construction Of Corporate Headquarters-
Proceeds From Sale Of Future Revenue290.00
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-275.00
Effect of exchange rate on cash flow71.00
Discontinued operations0.00
Free Cash Flow284.00
Total Cash Flow77.00
4 historic quarters locked

Sign in to unlock the full Elanco Animal Health Incorporated cash flow history.

Sign In Create Free Account

About Elanco Animal Health Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 24, 2026
  • Source: elan-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001739104-26-000012

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License